Atlas Trials

A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®

Clinical trial NCT01913353 · COMPLETED

Trial details

NCT number
NCT01913353
Sponsor
Bavarian Nordic
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
18-42 Year Old Healthy Vaccinia-naïve Subjects
Start date
2015-03-01
Primary completion
2017-03-01
Enrollment
440

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.